Northeast Financial Consultants Inc Siga Technologies Inc Transaction History

Northeast Financial Consultants Inc

  • $2.25 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 29, 2020
SELL
$5.62 - $7.68 $715,645 - $977,963
-127,339 Closed
0 $0
Q2 2020

Jul 30, 2020
BUY
$4.55 - $6.19 $341,250 - $464,250
75,000 Added 143.3%
127,339 $753,000
Q3 2018

Nov 08, 2018
BUY
$6.03 - $8.34 $315,604 - $436,507
52,339 New
52,339 $360,000

Others Institutions Holding SIGA

# of Institutions
184
Shares Held
35.6M
Call Options Held
873K
Put Options Held
466K
View Full List

About SIGA TECHNOLOGIES INC

SIGA Quotes by TradingView
  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $434M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email